| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |